Apax, an independent global firm focused solely on long-term investments, agreed to acquire Rodenstock, a global provider of high-quality ophthalmic lenses, from Compass Partners, a private equity firm. Financial terms were not disclosed. “Rodenstock fits perfectly with the Apax Funds’ healthcare strategy of investing in innovative companies with a differentiated customer proposition and the potential to achieve stand-out growth. Under Anders’ management, Rodenstock’s strategic refocus has already translated into strong performance in 2019 and 2020, despite the Covid-19 pandemic, creating a robust foundation for future success," Steven Dyson, Apax Partner and Co-Head of Healthcare.